| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1099-081X(199801)19:1<55::AID-BDD74>3.0.CO;2-H |
| P698 | PubMed publication ID | 9510985 |
| P2093 | author name string | Regårdh CG | |
| Renberg L | |||
| Teger-Nilsson AC | |||
| Eriksson UG | |||
| Bredberg U | |||
| P433 | issue | 1 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 55-64 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Biopharmaceutics and Drug Disposition | Q15766879 |
| P1476 | title | Animal pharmacokinetics of inogatran, a low-molecular-weight thrombin inhibitor with potential use as an antithrombotic drug | |
| P478 | volume | 19 |
| Q35852289 | A new oral anticoagulant: the 50-year challenge |
| Q43548556 | Estimation of human drug clearance using multiexponential techniques |
| Q30782163 | Evaluation of rat intestinal absorption data and correlation with human intestinal absorption |
| Q44103368 | Influence of structural variations in peptidomimetic 4-amidinophenylalanine-derived thrombin inhibitors on plasma clearance and biliary excretion in rats |
| Q78018827 | Inhibition of binding of an enzymatically stable thrombin inhibitor to lumenal proteases as an additional mechanism of intestinal absorption enhancement |
| Q34011214 | Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs |
| Q58863348 | Protease inhibitors – Part 3. Synthesis of non-basic thrombin inhibitors incorporating pyridinium-sulfanilylguanidine moieties at the P1 site |
| Q31373332 | Protease inhibitors. Part 2. Weakly basic thrombin inhibitors incorporating sulfonyl-aminoguanidine moieties as S1 anchoring groups: synthesis and structure-activity correlations |
| Q31440387 | Protease inhibitors: Part 4. Synthesis of weakly basic thrombin inhibitors incorporating pyridinium-sulfanilylaminoguanidine moieties |
| Q33540693 | Synthetic inhibitors of thrombin and factor Xa: from bench to bedside |
| Q43588740 | The effects of oral and intravenous direct thrombin inhibitors on the size of photochemically induced cortical infarction in rats |
| Q35159124 | The pharmacodynamics and pharmacokinetics of the oral direct thrombin inhibitor ximelagatran and its active metabolite melagatran: a mini-review |
Search more.